Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
Subscribe To Our Newsletter & Stay Updated
